Immunology
Pipeline

About our Immunology efforts

Our R&D strategy is inspired by the courage of patients living with debilitating, life-limiting auto-immune conditions. We are taking bold steps to deliver scientific breakthroughs that target, repair and prevent these diseases. Specific areas of focus include inflammatory skin diseases and inflammatory bowel diseases such as Crohn’s Disease and Ulcerative Colitis.

Read more about Avenciguat (BI 685509): sGC activator | SSc

Immunology

Systemic sclerosis

sGC activator

Avenciguat (BI 685509)

Read more about Nerandomilast (BI 1015550)

Immunology

Systemic Sclerosis

PDE4B inhibitor

Nerandomilast (BI 1015550)

Read more about Spesolimab (BI 655130): IL36R antibody

Immunology

Hidradenitis suppurativa

IL36R antibody

Spesolimab (BI 655130)

Read more about Spesolimab (BI 655130): IL36R antibody

Immunology

Netherton syndrome

IL36R antibody

Spesolimab (BI 655130)

Read more about Spesolimab (BI 655130): IL36R antibody | PG

Immunology

Pyoderma gangrenosum

IL36R antibody

Spesolimab (BI 655130)

Read more about Immunomodulator

Immunology

Immunomodulator

Read more about PD-1 antibody

Immunology

PD-1 antibody

Read more about TREM-1 Antibody

Immunology

TREM-1 antibody